Pharmaceutical gelatin is a translucent, colorless, flavorless, and a gentle substance which has a high molecular weight. The pharmaceutical gelatin is derivative from the skin, white connective tissues, and bones of animals by the partial hydrolysis of collagen. Majorly used for pharmaceutical gelatin are used in the pharmaceutical industries owing to the absorbable nature. They are also used to maintain the stability of pharmaceutical suspensions that serves a substitute for plasma. These are also widely used as a gelling agent in applications such as medications, drugs and vitamin capsules. Moreover, the gelatin serves rich source of protein and also used as a plasma substitute, absorbable film and surgical procedures.
Use of the pharmaceutical gelatin also offers manufacturers of drugs and supplements a versatile incipient used in the pharmaceutical industry from the decades. Gelatin is also an important raw material for production of hard and soft capsules over film-coated and effervescent tablets. The manufacturers also make use of unique adhesive, gelling and film-building properties. The administered medicines and dietary supplements are protected by gelatin-containing capsules or the tablets from light, moisture and oxygen.
According to study, “Global Pharmaceutical Gelatin Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use” the key companies operating in the global pharmaceutical gelatin market are KindKnox, Kenney & Ross, Roxlor LLC, Aspire Pharmaceuticals, Elnova Pharma, Er-kang Pharma, Ital, Nittm, Welshardt, Rousselot, HX Gelatin, Xiamen Gelken Gelatin, Gelita, Dongbao Bio-tech.
Based on source type, pharmaceutical gelatin market is segmented into pig skin, bones, bovine hides, and others. Based on function, market is segmented into stabilizers, gelling agents, thickeners, and others. In addition, based on application, market is segmented into micro-encapsulation, soft capsules, hard capsules, coating for tablets and absorbable hemostat. The manufactures of such capsules have their filling to take place over a single production step. Similar to the hard capsules, the gelatin capsules also have a property to protect ingredients which are sensitive to light, oxygen-induced degradation, and facilitating oral administration.
The pharmaceutical gelatin market is driven by increase in application in the pharmaceutical industry, followed by rise in aging population, increase in awareness about nutritional food and growth in nutraceutical industries. However, high cost of gelatin and increase in competition from gelatin alternatives may impact the market. Moreover, emerging economies to provide high-growth opportunities is a key opportunity for market.
Based on geography, the European and North-American regions hold major share in pharmaceutical gelatin market owing to increase in implementation of strict regulatory mandates and growth in pharmaceutical and food & beverage industries in the regions. Whereas, the Asian-Pacific region is estimated to witness higher growth rate due to rise in adoption of healthier product coupled with growth in population over the forecast period. In upcoming years, it is predicted that future of the market will be bright as a result of nutrient and high protein content in gelatin during the forecast period.
COVID 19Industrial Impact:
TheCOVID-19 outbreak started in China and lockdowns were imposed in different regions, this has significantly impacted the supply from the manufacturing facilities have been considerably reduced. Moreover, it is difficult to quantify as limited numbers of the typical workforce have been able to return to work.
For More Information, click on the link below:-
Ankur Gupta, Head Marketing & Communications